Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Cartesian Therapeutics said it has received rare pediatric disease designation from the U.S. Food and Drug Administration for its Descartes-08 treatment of juvenile dermatomyositis.
Pharmabiz12d
US FDA grants rare paediatric disease designation to Cartesian Therapeutics’ Descartes-08 to treat juvenile dermatomyositis
US FDA grants rare paediatric disease designation to Cartesian Therapeutics’ Descartes-08 to treat juvenile dermatomyositis: Gaithersburg, Maryland Tuesday, September 10, 2024, ...
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
Descartes-08, Cartesian’s lead mRNA cell therapy candidate, is an autologous mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T) product candidate targeting B-cell maturation antigen ...
Cartesian's Descartes-08 Granted Rare Pediatric Disease Designation By FDA To Treat JDM
Cartesian Therapeutics, Inc. (RNAC), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, ...
Are blood pressure tablets the reason I get dizzy when gardening? DR ELLIE has the answer
I'm 87 and whenever I do some weeding in my garden, I get really dizzy. I take losartan for my blood pressure and have ...
SciELO6d
Transient, self-limiting, antibody-negative myositis with venetoclax
Dermatomyositis was excluded because the patient did not have typical cutaneous features (heliotrope rash, Gottron papules, shawl sign). Inclusion body myositis was excluded because there was no ...
SciELO8d
Anti MDA-5 associated rapidly progressive interstitial lung disease complicated by viral pneumonia - a fatal outcome
Dermatomyositis is a heterogeneous systemic disease ... He developed a generalized erythematous macular rash for six months. No redness or warmth of the joints was noted. No photosensitivity, sicca ...